Increased Serum Netrin-1 Is Associated With Improved Prognosis of Ischemic Stroke

Author:

Guo Daoxia1,Zhu Zhengbao12,Zhong Chongke12,Peng Hao1,Wang Aili1,Xu Tian3,Peng Yanbo4,Xu Tan1,Chen Chung-Shiuan2,Li Qunwei5,Ju Zhong6,Geng Deqin7,Chen Jing2,Zhang Yonghong12,He Jiang2

Affiliation:

1. From the Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, China (D.G., Z.Z., C.Z., H.P., A.W., Y.Z., Tan Xu, Y.Z.)

2. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (Z.Z., C.Z., C.-S.C., J.C., J.H.)

3. Department of Neurology, Affiliated Hospital of Nantong University, Jiangsu, China (Tian Xu)

4. Department of Neurology, Affiliated Hospital of Hebei United University, China (Y.P.)

5. Department of Epidemiology, School of Public Health, Taishan Medical College, Shandong, China (Q.L.)

6. Department of Neurology, Kerqin District First People’s Hospital of Tongliao City, Inner Mongolia, China (Z.J.)

7. Department of Neurology, Affiliated Hospital of Xuzhou Medical College, Jiangsu, China (D.J.)

Abstract

Background and Purpose— Previous experimental studies suggested that serum netrin-1 was associated with the progression of ischemic stroke. Knowledge about netrin-1 among ischemic stroke patients may provide new ideas for the prognostic assessment of ischemic stroke. The aim of this study was to investigate the association between serum netrin-1 and prognosis of ischemic stroke. Methods— Serum netrin-1 levels at baseline were measured for 3346 ischemic stroke patients from the CATIS (China Antihypertensive Trial in Acute Ischemic Stroke), and all patients were followed up at 3 months after stroke onset. The primary outcome was a combination of death and major disability (modified Rankin Scale score of ≥3) within 3 months after stroke onset. Results— Up to 3 months after stroke onset, 845 patients (25.25%) experienced death or major disability. After adjustment for baseline National Institutes of Health Stroke Scale score and other potential confounders, elevated serum netrin-1 was associated with a decreased risk of primary outcome (odds ratio, 0.65; 95% CI, 0.47–0.88; P trend =0.002) when 2 extreme quartiles were compared. Each SD increase of log-transformed netrin-1 was associated with 17% (95% CI, 7%–26%) decreased risk of primary outcome. Multivariable-adjusted spline regression models showed a negative linear dose-response relationship between serum netrin-1 and the risk of primary outcome ( P linearity =0.003). Adding netrin-1 quartile to a model containing conventional risk factors improved risk prediction for primary outcome (net reclassification improvement index =14.74%; P =0.002; integrated discrimination improvement =0.40%; P =0.005). Conclusions— Elevated serum netrin-1 levels were associated with improved prognosis at 3 months after ischemic stroke, suggesting that serum netrin-1 may be a potential prognostic biomarker for ischemic stroke. Further studies from other samples of ischemic stroke patients are needed to replicate our findings and to clarify the potential mechanisms. Clinical Trial Registration— URL: https://www.clinicaltrials.gov . Unique identifier: NCT01840072.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3